Electrosteel Castings (500128) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
25 Oct, 2026Executive summary
Weak Jal Jeevan Mission funding and delayed government spending reduced domestic demand, volumes and profitability; a prior-period tax-provision reversal supported reported Q2 EBITDA.
Management described the slowdown as temporary and expects demand to recover from calendar 2026; water infrastructure programs and the T.I.S. acquisition broaden growth prospects.
Financial highlights
Consolidated Q2 FY26 total income was Rs. 149,094.86 lakh, EBITDA INR 188 crore and PAT Rs. 7,828.55 lakh; total income, EBITDA and PAT declined YoY.
Consolidated Q2 EBITDA excluding the INR 64 crore provision write-back was INR 124 crore; Q2 EBITDA margin was 12.6% and PAT margin was 5.3%.
H1 FY26 consolidated total income was INR 3,077 crore, EBITDA INR 386 crore and PAT INR 167 crore; all declined YoY.
Standalone Q2 total income was Rs. 119,232.20 lakh and PAT Rs. 7,599.35 lakh; EBITDA margin was 13.5%.
DI fittings and CI pipe sales volume was 1.39 lakh tonnes in Q2, down 28% YoY; H1 volume was 3.02 lakh tonnes, down 25%, while export volume rose 8%.
Outlook and guidance
FY26 volume guidance was 5.5–6 lakh tonnes; FY27 volume was projected at 8–8.5 lakh tonnes as funding and demand recover.
Management expects production and per-tonne margins to improve from Q1 FY27, with a stronger pickup in Q2; double-digit margin per tonne was described as achievable.
Quarterly net profit was expected to approach INR 150 crore by Q2 FY27, subject to the anticipated recovery.
T.I.S. valve sales in India, the Middle East and Southeast Asia are expected from FY27; its FY26 revenue was expected to grow 10% over its ~INR 350 crore prior-year base.
Latest events from Electrosteel Castings
- EBITDA doubled as DI pipe demand lifted Q1 results; legal exposures remain unresolved.500128
Q1 24/25 - H1 growth and FY26 expansion plans contrasted with weaker Q2 and qualified review.500128
Q2 24/25 - Shutdown-hit Q3 contrasted with nine-month growth and capacity expansion amid unresolved audit matters.500128
Q3 24/25 - Shutdown-hit FY25 earnings, capacity expansion and unresolved audit matters define the outlook.500128
Q4 24/25 - Funding slowdown cut Q1 earnings; H2 recovery and T.I.S. valve expansion shape the outlook.500128
Q1 25/26 - JJM delays weakened Q3 earnings; exports and funding resumption underpin recovery hopes.500128
Q3 25/26 - FY26 earnings fell on weak domestic demand; gradual recovery faces cost and audit risks.500128
Q4 25/26 - Lower Q1 earnings amid delayed water projects and unresolved legal exposures.500128
Q1 26/27